| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 87.90B | 94.34B | 99.73B | 99.73B | 85.16B | 87.10B |
| Gross Profit | 8.49B | 7.46B | 7.64B | 6.29B | 6.95B | 6.01B |
| EBITDA | 6.37B | 6.67B | 3.17B | 3.19B | 3.62B | 3.17B |
| Net Income | 2.03B | 2.08B | -71.00M | -2.05B | -1.21B | -3.08B |
Balance Sheet | ||||||
| Total Assets | 77.81B | 78.33B | 81.18B | 82.90B | 80.16B | 82.28B |
| Cash, Cash Equivalents and Short-Term Investments | 15.70B | 15.23B | 12.29B | 17.28B | 19.71B | 20.07B |
| Total Debt | 2.42B | 3.56B | 6.86B | 9.95B | 8.62B | 8.86B |
| Total Liabilities | 23.43B | 25.29B | 29.91B | 34.02B | 30.38B | 32.69B |
| Stockholders Equity | 54.02B | 52.70B | 50.85B | 48.51B | 49.43B | 49.26B |
Cash Flow | ||||||
| Free Cash Flow | -755.00M | 690.00M | -963.00M | -2.43B | -411.00M | 462.00M |
| Operating Cash Flow | 2.46B | 2.77B | 958.00M | -787.00M | 3.50B | 3.04B |
| Investing Cash Flow | -1.51B | 4.50B | -1.21B | -2.05B | -3.46B | -2.72B |
| Financing Cash Flow | -1.32B | -4.99B | -5.00B | -30.00M | -1.33B | 4.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥24.16B | 9.48 | ― | 5.56% | 3.55% | 27.86% | |
79 Outperform | ¥22.30B | 9.59 | ― | 2.86% | 19.42% | 74.63% | |
71 Outperform | ¥22.52B | 11.42 | ― | 2.70% | -8.63% | -55.68% | |
62 Neutral | ¥20.84B | 4.87 | ― | 4.58% | 34.99% | 468.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
51 Neutral | ¥32.17B | 130.91 | ― | 2.45% | 4.93% | ― | |
47 Neutral | ¥32.09B | 25.56 | ― | 3.33% | -3.91% | -36.53% |